Other available languages:
Dr. G. JACOBSON et al.
University of Tasmania, Australia
University of Copenhagen, Denmark
Prof. X. de la Torre et al.
Federazione Medico Sportiva Italiana, Italy
Freie Universität, Germany
International Olympic Committee Anti-Doping Rules applicable to the 2018 Buenos Aires Youth Olympic Games.
Dr. J. Pascual, Dr. J. Segura
Fundacio IMIM (FIMIM), Spain
Note: Revised to incorporate recently approved versions of Technical Documents in sections 3.2 and 3.3.
Dr. M. Thevis
Center for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Germany
X. de la TORRE
Federazione Medicio Sportiva Italiana, Italy
WADA annually publishes statistical reports as reported by the WADA-accredited laboratories in ADAMS.
Previous testing figures reports can currently be found under Archives.
Medical Information to Support the Decisions of TUE (Therapeutic Use Exemptions) Committees - also called TUE Physician Guidelines - on Cardiovascular Conditions: The Therapeutic Use of Beta-blockers in Athletes.
Dr. S. Iljukov, Prof. S. Bermon
Research Institute for Olympic Sports, Finland
In keeping with article 9(a) of the World Anti-Doping Agency’s (WADA’s) Intelligence and Investigations (I&I) Policy, on an annual basis, an Independent Supervisor, is required to conduct an audit of WADA’s I&I Department.
Medical Information to Support the Decisions of TUE (Therapeutic Use Exemptions) Committees - also called TUE Physician Guidelines - on Intravenous Infusion.
As part of its role in providing guidance to anti-doping organisations, the World Anti-Doping Agency (WADA) publishes a global list of Athlete Support Personnel who are currently suspended from working with Athletes or other Persons under the 2015 World Anti-Doping Code’s new, ‘Prohibited Associa